FSAD or sexual dysfunction as order the appropriate mental health secondary to a mental health DBQ as well as the gynecological disability and the examination DBQ. threshold described in is met any gynecological condition and the ask the examiner to determine examination threshold described in is whether FSAD is present. met Include the following language in all gynecological exam Important: requests, even if FSAD is not specifically claimed: Examiner: Please whether the Veteran has a diagnosis of Female Sexual Arousal Disorder (FSAD). If additional examination(s) are required, please request and/or perform as necessary. If SC for FSAD is not expressly claimed, it will not be inferred unless Note: a claim for sexual dysfunction or other gynecological disability can be reasonably interpreted as a claim for FSAD. c. Evaluating When the requirements for SC are met, FSAD will be awarded as a FSAD disability using with a 0-percent evaluation. This is the maximum evaluation available for FSAD. Notes: Entitlement to SMC (k) for loss of use of a creative organ will be inferred and awarded whenever SC for FSAD is granted. If SC was previously established for FSAD but SMC was not awarded, place entitlement to SMC at issue and grant. The effective date for the award of SMC will be the date SC for FSAD was established. The clarification that FSAD is a disorder subject to SC is not a regulatory change. Consequently, the provisions of do not apply for assignment of the effective date. d. Considering Do not routinely award SC for fibrocystic breast disease. Although this Claims for SC condition is termed a disease, it is actually a physiologic finding that is of Fibrocystic generally acute and transient. In the absence of associated pathology, SC is Breast Disease not warranted. Additionally, fibrocystic breasts are not associated with increased risk of breast cancer unless the changes are associated with atypical hyperplasia. Examples of associated pathology that warrant SC for fibrocystic breast may disease are persistent or thickening requiring surgical excision, or fibrocystic breast changes with associated atypical hyperplasia.
FSAD or sexual dysfunction as secondary to a mental health disability and the examination threshold described in is met order the appropriate mental health DBQ as well as the gynecological DBQ. any gynecological condition and the examination threshold described in is met ask the examiner to determine whether FSAD is present. Important: Include the following language in all gynecological exam requests, even if FSAD is not specifically claimed: Examiner: Please whether the Veteran has a diagnosis of Female Sexual Arousal Disorder (FSAD). If additional examination(s) are required, please request and/or perform as necessary. Note: If SC for FSAD is not expressly claimed, it will not be inferred unless a claim for sexual dysfunction or other gynecological disability can be reasonably interpreted as a claim for FSAD. c. Evaluating FSAD When the requirements for SC are met, FSAD will be awarded as a disability using with a 0-percent evaluation. This is the maximum evaluation available for FSAD. Notes: Entitlement to SMC (k) for loss of use of a creative organ will be inferred and awarded whenever SC for FSAD is granted. If SC was previously established for FSAD but SMC was not awarded, place entitlement to SMC at issue and grant. The effective date for the award of SMC will be the date SC for FSAD was established. The clarification that FSAD is a disorder subject to SC is not a regulatory change. Consequently, the provisions of do not apply for assignment of the effective date. d. Considering Claims for SC of Fibrocystic Breast Disease Do not routinely award SC for fibrocystic breast disease. Although this condition is termed a disease, it is actually a physiologic finding that is generally acute and transient. In the absence of associated pathology, SC is not warranted. Additionally, fibrocystic breasts are not associated with increased risk of breast cancer unless the changes are associated with atypical hyperplasia. Examples of associated pathology that may warrant SC for fibrocystic breast disease are persistent or thickening requiring surgical excision, or fibrocystic breast changes with associated atypical hyperplasia.